Cargando…

The association between electronic cigarettes, sleep duration, and the adverse cardiovascular outcomes: Findings from behavioral risk factor surveillance system, 2020

The joint effect of electronic cigarette smoking and insufficient sleep duration on cardiovascular disease (CVD) was unclear. This cross-sectional study aimed to evaluate the association between electronic cigarettes, sleep duration, and risk of CVD among American adults. The participants who comple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xingyou, Yuan, Zhichao, Ji, Yuelong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582666/ https://www.ncbi.nlm.nih.gov/pubmed/36277785 http://dx.doi.org/10.3389/fcvm.2022.909383

Ejemplares similares

Electronic Cigarette Use and the Risk of Cardiovascular Diseases
por: Espinoza-Derout, Jorge, et al.
Publicado: (2022)

Sleep Quality, Sleep Duration, and the Risk of Adverse Clinical Outcomes in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
por: Zhu, Chun-Yan, et al.
Publicado: (2022)

Associations between sleep duration and cardiovascular diseases: A meta-review and meta-analysis of observational and Mendelian randomization studies
por: Wang, Shanshan, et al.
Publicado: (2022)

Mediating effects of lower extremity function on the relationship between night sleep duration and cardiovascular disease risk: a cross-sectional study in elderly Chinese without cardiovascular diseases
por: Zhang, Hui, et al.
Publicado: (2021)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: D’Amario, Domenico, et al.
Publicado: (2019)

Nonlinear associations between sleep duration and the risks of all-cause and cardiovascular mortality among the general adult population: a long-term cohort study
por: Li, Jie, et al.
Publicado: (2023)

Examining the U-shaped relationship of sleep duration and systolic blood pressure with risk of cardiovascular events using a novel recursive gradient scanning model
por: Yang, Shuo, et al.
Publicado: (2023)

Short sleep duration associated with increased risk for new-onset cardiovascular diseases in individuals with metabolic syndromes: Evidence from the China Health and Retirement Longitudinal Study
por: Sun, Jiaxin, et al.
Publicado: (2022)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Orimoloye, Olusola A, et al.
Publicado: (2019)

Editorial: Sleep disorders, hypertension and cardiovascular diseases
por: Bisogni, Valeria, et al.
Publicado: (2022)

Does the Prevalence of Dyslipidemias Differ between Newfoundland and the Rest of Canada? Findings from the Electronic Medical Records of the Canadian Primary Care Sentinel Surveillance Network
por: Asghari, Shabnam, et al.
Publicado: (2015)

Editorial: The biological impact of adversity on cardiovascular disease risk and obesity
por: Baumer, Yvonne, et al.
Publicado: (2022)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Establishing plausibility of cardiovascular adverse effects of immunotherapies using Mendelian randomisation
por: Le, Nhu Ngoc, et al.
Publicado: (2023)

Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
por: Chen, Yiru, et al.
Publicado: (2023)

An integral perspective of canonical cigarette and e-cigarette-related cardiovascular toxicity based on the adverse outcome pathway framework
por: Ding, Ruiyang, et al.
Publicado: (2022)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Sleep duration, daytime napping, and risk of incident stroke: Nuances by metabolic syndrome from the China health and retirement longitudinal study
por: Fang, Yuanyuan, et al.
Publicado: (2022)

Visit-to-Visit Heart Rate Variability Is Positively Associated With the Risk of Adverse Cardiovascular Outcomes
por: Zeng, Rong, et al.
Publicado: (2022)

The Association of Sleep Duration and the Use of Electronic Cigarettes, NHANES, 2015-2016
por: Wiener, R. Constance, et al.
Publicado: (2020)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Associations between common sleep disturbances and cardiovascular risk in patients with obstructive sleep apnea: A large-scale cross-sectional study
por: Zhang, Xiaoman, et al.
Publicado: (2022)

Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study
por: Zheng, Yan, et al.
Publicado: (2022)

Sleep duration and risk of cardio-cerebrovascular disease: A dose-response meta-analysis of cohort studies comprising 3.8 million participants
por: Huang, Yi-Ming, et al.
Publicado: (2022)

Trends in the prevalence of elevated cardiovascular risk and the control of its risk factors Among US adults, 2001–2020
por: Huang, Haitao, et al.
Publicado: (2023)

Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Lee, Jane J., et al.
Publicado: (2021)

Study title: A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use
por: Kim, Mimi M., et al.
Publicado: (2023)

Editorial: Advances in predicting future adverse coronary events: the role of cardiovascular imaging and coronary physiology indices
por: Seitun, Sara, et al.
Publicado: (2023)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes Trials
por: Wong, Nathan D., et al.
Publicado: (2019)

Cardiovascular magnetic resonance findings in Danon disease: a case series of a family
por: Liu, Xiaolong, et al.
Publicado: (2023)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Relation Between Plasma Proteomics Analysis and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Dregoesc, Mihaela Ioana, et al.
Publicado: (2022)

Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study
por: Liu, Lu, et al.
Publicado: (2022)

Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease
por: Qian, Ke, et al.
Publicado: (2022)

Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022
por: Wu, Si, et al.
Publicado: (2022)

Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study
por: Boreskie, Kevin F, et al.
Publicado: (2017)

Protocol for assessment of sleep quality and duration in the Treatment In Morning versus Evening (TIME) study: a randomised controlled trial using online patient-reported outcome measures
por: Rogers, Amy, et al.
Publicado: (2018)

Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States
por: Zhai, Yinghong, et al.
Publicado: (2021)

Leukocyte Telomere Length Shortening Implies Plaque Instability and Major Adverse Cardiovascular Events in Patients With Angiographically Intermediate Lesions
por: Zhang, Alian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_unvgf85leh5qp7ub6an4po25fr